Key result
A 76-year-old male presenting with syncope and ATTR-CM dies 5 years after ICD implantation.
Why the study?
Syncope requires a thoughtful approach to history-taking to discern cardiac versus non-cardiac etiologies.
Population
A 76-year-old male presenting following an episode of syncope with abrupt loss of consciousness
Design
Case report
Follow-up
5 years after his diagnosis
Authors
Loading...
Cardiac amyloidosis merits consideration in unexplained syncope; leaves open ICD survival benefit in ATTR-CA.
Case Report (n=1)
Cardiac amyloidosis is a rare but important cause of cardiogenic syncope that requires structural cardiac evaluation when suspected.
Strelow et al. (2024) conducted a case report in Syncope and Transthyretin (ATTR) cardiac amyloidosis (n=1). Dual chamber implantable cardioverter defibrillator (ICD) was evaluated. A 76-year-old male presenting with syncope was diagnosed with transthyretin cardiac amyloidosis and treated with an ICD, ultimately succumbing to the disease 5 years after diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: